Selective Knockout of the Vesicular Monoamine Transporter 2 (Vmat2) Gene in Calbindin2/Calretinin-Positive Neurons Results in Profound Changes in Behavior and Response to Drugs of Abuse
Open Access
- 9 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 14
Abstract
The vesicular monoamine transporter 2 (VMAT2) has a range of functions in the central nervous system, from sequestering toxins to providing conditions for quantal release of monoaminergic neurotransmitters. Monoamine signaling regulates diverse functions from arousal to mood, movement, and motivation, and dysregulation of VMAT2 function is implicated in various neuropsychiatric diseases. While all monoamine-releasing neurons express the Vmat2 gene, only a subset is positive for the calcium-binding protein Calbindin 2 (Calb2; aka Calretinin, 29 kDa Calbindin). We recently showed that about half of the dopamine neurons in the mouse midbrain are positive for Calb2, and that Calb2 is an early developmental marker of midbrain dopamine cells. Calb2-positive neurons have also been identified in other monoaminergic areas, yet the role of Calb2-positive monoaminergic neurons is poorly understood. To selectively address the impact of Calb2-positive monoaminergic neurons in behavioral regulation, we took advantage of the Cre-LoxP system to create a new conditional knockout (cKO) mouse line in which Vmat2 expression is deleted selectively in Calb2-Cre-positive neurons. In this Vmat2lox/lox;Calb2-Cre cKO mouse line, gene targeting of Vmat2 was observed in several distinct monoaminergic areas. By comparing control and cKO mice in a series of behavioral tests, specific dissimilarities were identified. In particular, cKO mice were smaller than control mice, and showed heightened sensitivity to the stereotypy-inducing effects of amphetamine and slight reductions in preference toward sucrose and ethanol, as well as a blunted response in the elevated plus maze test. These data uncover new knowledge into the role of genetically defined subtypes of neurons in the brain's monoaminergic systems.Keywords
Funding Information
- Hjärnfonden
- Vetenskapsrådet
- Bertil Hållstens Forskningsstiftelse
- O. E. och Edla Johanssons Vetenskapliga Stiftelse
- Stiftelsen Zoologisk Forskning
- Åhlén-stiftelsen
- Parkinsonfonden
- Uppsala Universitet
This publication has 79 references indexed in Scilit:
- Distribution of parvalbumin, calbindin and calretinin containing neurons and terminal networks in relation to sleep associated nuclei in the brain of the giant Zambian mole-rat (Fukomys mechowii)Journal of Chemical Neuroanatomy, 2013
- Brain Dopamine–Serotonin Vesicular Transport Disease and Its TreatmentNew England Journal of Medicine, 2013
- CNS Dopamine Transmission Mediated by Noradrenergic InnervationThe Journal of Neuroscience, 2012
- Functional interactions between the paraventricular hypothalamic nucleus and raphe magnus. A comparative study of an integrated homeostatic analgesic mechanismNeuroscience, 2012
- Severe Serotonin Depletion after Conditional Deletion of the Vesicular Monoamine Transporter 2 Gene in Serotonin Neurons: Neural and Behavioral ConsequencesNeuropsychopharmacology, 2011
- Control of Breathing by Raphe Obscurus Serotonergic Neurons in MiceThe Journal of Neuroscience, 2011
- Vmat2Heterozygous Mutant Mice Display a Depressive-Like PhenotypeJournal of Neuroscience, 2007
- The use of the elevated plus maze as an assay of anxiety-related behavior in rodentsNature Protocols, 2007
- Genome-wide atlas of gene expression in the adult mouse brainNature, 2006
- SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholismHuman Molecular Genetics, 2005